ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
17.932,17
-1,10%
S&P 500
5.078,42
-0,74%
Dow Jones
38.065,50
-0,84%
Euro vs US Dollar
1,06766
-0,36%
Bitcoin
60.350,23
-5,46%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Alvontech (ALVO)

  7. Alvontech (ALVO) News

ALVO Alvontech

14,58
0,36 (2,53%)
Zuletzt aktualisiert: 19:46:18
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Alvontech ALVO NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,36 2,53% 14,58 19:46:18
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
14,67 14,46 14,76 14,22
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
30.4.202410:00GLOBEU.S. Commercialization Agreement with Quallent to Drive..
24.4.202410:00GLOBEAlvotech Announces Topline Results from a Confirmatory..
19.4.202412:10GLOBEAlvotech signs U.S. agreement to expand access for newly..
16.4.202423:43BWAlvotech and Teva Announce U.S. FDA Approval of SELARSDI™..
16.4.202423:30GLOBEAlvotech and Teva Announce U.S. FDA Approval of SELARSDI™..
03.4.202413:41GLOBEAlvotech Hosts Audio Call for Investors at 8:15 am EDT on..
22.3.202421:15GLOBEAlvotech Announces Increase in Number of Own Shares
20.3.202421:15GLOBEAlvotech Reports Financial Results for Full Year 2023 and..
20.3.202412:17IHMARKETNEWSU.S. Index Futures Trade Sideways Amid Anticipation of Fed’s..
05.3.202422:00GLOBEAlvotech Announces Webcast of Full Year 2023 Financial..
29.2.202422:05GLOBEAlvotech Appoints Interim Chief Quality Officer
26.2.202410:25GLOBEAlvotech Accepts Offer for the Sale of Shares for a value of..
24.2.202402:15GLOBEAlvotech and Teva Announce U.S. Approval of SIMLANDI®..
24.2.202402:15BWAlvotech and Teva Announce U.S. Approval of SIMLANDI®..
15.2.202412:30GLOBEAlvotech Announces Expected Global Market Entry Dates for..
29.1.202410:00GLOBEAlvotech Announces Positive Top-Line Results from a..
19.1.202418:31DJNAlvotech Shares Climb After FDA Concludes Facility..
19.1.202417:30GLOBEAlvotech Provides Update on Status of Biologics License..
10.1.202409:30GLOBESTADA and Alvotech secure approval for Uzpruvo, Europe’s..
03.1.202409:30GLOBEAlvotech Clinical Study Results Demonstrate Therapeutic..
29.11.202310:00GLOBEAlvotech Announces Positive Top-Line Results from a..
28.11.202322:15GLOBEAlvotech Reports Financial Results for First Nine Months of..
21.11.202314:00GLOBEAlvotech to Report Financial Results for the First Nine..
14.11.202313:00GLOBEAlvotech and JAMP Pharma Announce Receipt of Marketing..
10.11.202315:30GLOBESTADA and Alvotech receive positive CHMP opinion for..
07.11.202314:00GLOBEAlvotech to Present at the Jefferies 2023 London Healthcare..
12.10.202310:00GLOBEAlvotech Provides Update on Status of U.S. Biologics License..
03.10.202314:29BWKashiv BioSciences Enters into Exclusive Licensing Agreement..
03.10.202311:00GLOBEAlvotech Enters into Exclusive Licensing Agreement with..
25.9.202310:00GLOBEAlvotech Announces Approval in Japan of AVT04 (ustekinumab),..
20.9.202310:30GLOBEAlvotech Provides U.S. Regulatory Update on AVT02, a..
05.9.202315:30GLOBEAlvotech Announces Changes to the Leadership Team
30.8.202322:15GLOBEAlvotech Reports Financial Results for First Six Months of..
29.8.202311:00GLOBEAlvotech and Bioventure Announce Approval of AVT02..
22.8.202315:15GLOBEAlvotech to Report Financial Results for the First Half of..
31.7.202310:00GLOBEAlvotech Completes $100 Million Convertible Bond Private..
24.7.202310:00GLOBETeva Pharmaceuticals and Alvotech Provide Update on..
03.7.202315:37DJNAlvotech Shares Rebound 20% After FDA Letter Selloff
29.6.202302:03DJNAlvotech Gets FDA Letter, Expects Delay in U.S. Approval of..
29.6.202301:00GLOBEAlvotech Provides Regulatory Update on Second Biologics..
12.6.202313:00BWAlvotech and Teva Secure U.S. License Date for AVT04, a..
12.6.202309:00GLOBEAlvotech and Teva Secure U.S. License Date for AVT04, a..
31.5.202311:20GLOBEAlvotech to Participate in Jefferies Healthcare Conference
24.5.202311:00GLOBEAlvotech and Advanz Pharma extend strategic partnership to..
19.5.202311:00GLOBEAlvotech Reports Financial Results for First three Months of..
17.5.202311:00GLOBEAlvotech to Participate in Morgan Stanley Annual..
15.5.202311:00GLOBEAlvotech Issues Annual Equality Report Covering 2022
10.5.202311:00GLOBEAlvotech enters into commercialization agreement with..
04.5.202311:00GLOBEAlvotech Initiates Confirmatory Patient Study for AVT05, a..
03.5.202315:00GLOBEAlvotech to Report First Quarter 2023 Financial Results and..

Kürzlich von Ihnen besucht

NASDAQ
ALVO
Alvontech
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten